Nano News
Looking inside Nanolive
Cytotoxic Drug Development Application Note
Discover how Nanolive’s LIVE Cytotoxicity Assay transforms cytotoxic drug development through high-resolution, label-free quantification of cell health and death. Our application note explores how this advanced technology enables real-time monitoring of cell death...
Investigative Toxicology Application Note
Our groundbreaking approach offers a label-free, high-content imaging solution that transforms the way cellular health, death, and phenotypic responses are monitored and quantified. Unlike traditional cytotoxicity assays, Nanolive’s technology bypasses the limitations...
Phenotypic Cell Health and Stress Application Note
Discover the advanced capabilities of Nanolive’s LIVE Cytotoxicity Assay in an application note. This document presents a detailed exploration of how our innovative, label-free technology enables researchers to monitor phenotypic changes and detect cell stress...
High-content Imaging for Drug Delivery Application Note
Discover how Nanolive’s advanced LIVE Cytotoxicity Assay can transform your drug delivery research. This application note details how our innovative, label-free technology enables precise monitoring of cell health and death in response to drug treatment. Explore how...
Newsletter June 2024: AI-powered Microscopy Reveals SARS-CoV-2 Impact on Organelle Dynamics
Welcome to the June edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live cell...
Online Demo: Transforming drug discovery with AI-powered live cell analysis
Reveal cellular stories with AI Join us for an exclusive demonstration tailored for biopharma professionals and academic researchers, showcasing Nanolive’s cutting-edge live cell imaging and analysis technology. Discover our unique holotomographic microscope and...
Newsletter May 2024: In vitro drug candidate profiling
Welcome to the first edition of the AI for Live Cell Insights newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live cell...
Revolutionizing lipid droplet analysis: insights from Nanolive’s Smart Lipid Droplet Assay Application Note
Introducing the Smart Lipid Droplet Assay: A breakthrough in label-free lipid droplet analysis Discover the power of Nanolive's Smart Lipid Droplet Assay (SLDA), the first smart digital assay to provide a push-button solution for analyzing lipid droplet dynamics,...
Food additives and gut health: new research from the University of Sydney
The team of Professor Wojciech Chrzanowski in the Sydney Pharmacy School at the University of Sydney have published their findings on the toxic effect of titanium nanoparticles found in food. The paper “Impact of nano-titanium dioxide extracted from food products on...
2023 scientific publications roundup
2023 has been a record year for clients using the Nanolive system in their scientific publications. The number of peer-reviewed publications has continued to increase, and there has been a real growth in groups publishing pre-prints to give a preview of their work....
Closer to understanding coronavirus: Research results with Institut Pasteur
Nanolive is proud to be part of a research collaboration with leading virologists from the group of Olivier Schwartz at the Institut Pasteur in Paris. The latest research from Nanolive’s Deep Quantitative Biology department and the Institut Pasteur uses cutting-edge...
Nanolive is exhibiting at the ASCB I EMBO Meeting, Cell Bio 2023. December 3 – 5 in Boston
Presentation Nanolive is delighted to invite you to attend our upcoming presentation at the Cell Bio Meeting in Boston on December 4, 2023, from 10:15am to 11:00am in Theatre 1. During our talk, “High-content label-free imaging for live phenotypic insights and...
Demo site inauguration at University of San Francisco
Nanolive is delighted to invite you for an upcoming exclusive in-person event at UC San Francisco, on November 17th, 2023, from 11.00am to 1.00pm. Nanolive delivers breakthrough label-free live cell and phenotypic solutions that combine screening, imaging and analysis...
Nanolive is exhibiting during the ESMO Congress 2023 October 20 – 23 in Madrid, Spain
💫Visit our booth:The world’s leading cancer research minds will converge at the ESMO Congress 2023. We are thrilled to announce that Nanolive will be exhibiting there from October 20 to 23, at Booth #560 in Hall 5! Come and meet our team and discover the...
Nanolive is attending the ELRIG Drug Discovery 2023 Conference October 18 – 19 in Liverpool, UK
Presentation Nanolive is delighted to invite you to attend our upcoming presentation at the ELRIG Drug Discovery 2023 Conference in Liverpool on October 18, 2023, from 16:15 to 16:30 in Auditorium 1. During our talk, “A powerful solution for high content label-free...
Seminar @ University of Stanford with Nanolive
Label-free live cell and phenotypic analysis solutions Nanolive is delighted to invite you to the Stanford Seminar with Nanolive at Stanford University, on October 30th, 2023, from 1:30pm to 3:00pm. Nanolive delivers breakthrough label-free live cell and phenotypic...
Nanolive at the SPS Annual Meeting September 18-20
Joint presentation with Sanofi Nanolive is delighted to invite for you to attend our upcoming joint presentation with Sanofi at the Safety Pharmacology Society (SPS) Annual Meeting in Brussels on September 20, 2023, from 12:30 PM to 1:30 PM in Studio 214. During our...
Webinar – High content in vitro imaging for translational success: targeted therapies
Nanolive hosts this event on "Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules". In this webinar, we present the following use-cases of our immuno-oncology and cytotoxicity...